We are live on
!
Find out more
SMC
S. Muoio & Co Portfolio holdings
AUM
$75.7M
1-Year Est. Return
42.51%
This Fund
S&P 500
This Quarter
Est. Return
+24.81%
1 Year Est. Return
+42.51%
3 Year Est. Return
+327.42%
5 Year Est. Return
+691.71%
10 Year Est. Return
–
AUM
$92.1M
AUM Growth
+$4.06M
(+4.6%)
Cap. Flow
-$8.9M
Cap. Flow
% of AUM
-9.66%
Top 10 Holdings %
Top 10 Hldgs %
34.61%
Holding
98
New
26
Increased
7
Reduced
15
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$2.63M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$2.57M |
| 3 |
Elanco Animal Health
ELAN
|
+$1.42M |
| 4 |
IPHI
INPHI CORPORATION
IPHI
|
+$1.41M |
| 5 |
RP
RealPage, Inc.
RP
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$4.25M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$3.15M |
| 3 |
AIMT
Aimmune Therapeutics
AIMT
|
+$3.1M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$3.05M |
| 5 |
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
|
+$2.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 20.46% |
| 2 | Consumer Discretionary | 13.38% |
| 3 | Technology | 12.51% |
| 4 | Financials | 8.98% |
| 5 | Healthcare | 8.39% |
Similar funds
FFMBT
NVPX
WM
RA
RC
GI
PM
PIMH
S. Muoio & Co's Q4 2020 Portfolio in Review
As of Q4 2020, S. Muoio & Co held 98 positions worth $92.1M, up 4.6% from $88M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
S. Muoio & Co withdrew a net $8.9M in Q4 2020, closing 20 positions and reducing 15 holdings. Its most notable exit was Immunomedics Inc, an estimated $4.25M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, S. Muoio & Co opened a new position in CONCHO RESOURCES INC. worth $2.92M.
- S. Muoio & Co's largest Q4 2020 buy was CONCHO RESOURCES INC.: 50,000 shares worth $2.92M.
- S. Muoio & Co added most to Elanco Animal Health in Q4 2020, an estimated $1.42M increase.
- S. Muoio & Co's biggest Q4 2020 reduction was AMC Global Media, cutting an estimated $1.18M.
- S. Muoio & Co fully exited Immunomedics Inc in Q4 2020, selling an estimated $4.25M.
- S. Muoio & Co's ten largest holdings make up 35% of its $92.1M portfolio in Q4 2020.
- S. Muoio & Co opened 26 new positions and closed 20 in Q4 2020.
- S. Muoio & Co's portfolio value rose 4.6% quarter-over-quarter to $92.1M.
Based on S. Muoio & Co's 13F filing for Q4 2020, filed 16 Feb 2021.